Robotic Centre
Paideia International Hospital’s Robotic Centre uses the very latest generation of robots: The Da Vinci Xi Robot is used mainly in urology, general surgery, gynaecology, thoracic surgery and otorhinolaryngology (ENT); the Mako Robot is used in orthopaedic surgery for hip and knee replacements; AquaBeam is used in urology.
Robot-assisted surgery embodies the development of surgery techniques in recent years and what makes a real difference is its minimally invasive approach that ensures significant benefits for patients.
Precision, agility, much shorter hospital stays and lower risks are the advantages of this unique technology featuring mechanical arms that surgeons can manoeuvre remotely as if they were an extension of their own hands.
Da Vinci Xi Robot
The Da Vinci Xi is the most advanced robotic system for minimally invasive surgery. Its technical features allow the robot to be used in various fields, fromurology to gynaecology, from thoracic surgery to general surgery.
Clinical benefits of robot-assisted surgery
Thanks to the greater precision of robot-assisted surgery compared to traditional surgery, the surgeon is able to avoid with greater ease the tissues and organs that are not affected by the disease, and to be more precise in the reconstruction stages. Patients treated with the Da Vinci Xi will therefore return to normal activities more quickly and without any particular post-surgery complications.
- Small incisions with reduced tissue trauma
- Less bleeding and reduced need for transfusions
- Shorter hospital stay and less post-operative pain
- Faster recovery time
- Faster return to daily activities
- Greater ease in performing complex surgical manoeuvres
- Improved patient safety
DA VINCI ROBOTIC SYSTEM’S MAIN AREAS OF APPLICATION
- General surgery
- Urological surgery
- Gynaecological surgery (in particular cancer-related)
- Vascular and thoracic surgery
Mako Robot
The Mako is the most advanced robotic system for minimally invasive orthopaedic prosthetic surgery. Its characteristics are: accuracy, precision and reproducibility of the surgical action.
The innovative Mako system is particularly recommended for degenerative joint diseases of the knee, such as arthrosis and osteoarthritis, that arise due to age and family history.
It allows maximum precision of the prosthesis while respecting each patient’s individual anatomy, balanced ligamentous tension, cartilage thickness, orientation, sliding and coupling between prosthetic components. The robotic arms allows the surgeon to reproduce with extreme precision on the patient the procedure planned in the software, eliminating manual error.
Clinical Benefits
- Visualising the specific anatomy of the patient in detail
- Precise pre-operative planning
- Greater precision in the surgical procedure and in the positioning of the prosthesis
- Significant reduction in pain
- Reduced hospital stay and post-operative recovery time
- Less bleeding
- Faster recovery
- Improved mobility and quality of life
- Extension of implant life
Thanks to the greater precision of robot-assisted surgery compared to traditional surgery, the surgeon is able to more easily avoid the tissues and organs that are not affected by the condition, as well as be more precise in the reconstruction stages. Patients treated with the Mako will therefore return to normal activities more quickly and without any particular post-surgery complications.
MAKO ROBOTIC SYSTEM’S MAIN AREAS OF APPLICATION
- Total knee replacement
- Partial knee replacement
- Hip replacement
AquaBeam
The AquaBeam system is a robotic device designed for the ablation and removal of prostate tissue in individuals with lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH).
This system works by combining three principles of action:
- Real-time image acquisition: intra-operative ultrasound guidance
- Robot-assisted procedure: planned and accurate removal of tissue performed robotically
- Water jet: hydrodissection of the target tissue without using thermal energy
Aquabeam reduces the likelihood of suffering ejaculation problems. For prostate sizes between 30g and 80g (85% of cases), the literature reports a sexual dysfunction rate of 0% after three years. For prostates between 80g and 150g, studies report 2% of cases with ejaculatory dysfunction and 1% with erectile dysfunction after two years.
